Novo-Torrent JV expands Gujarat unit
Leading diabetes-care pharmaceutical company Novo Nordisk, in partnership with Torrent Pharma, has inaugurated an enhanced facility in Indrad, Gujarat and is looking at launching more new products in India. Torrent has invested Rs 60 crore so far in the plant, which has an existing capacity of about 2.6 crore vials. There will be an increase of around 35 per cent in the capacity of the plant post-expansion. Dubbed as the diabetes capital of the world, India is home to 7.29 crore people with diabetes.